Accuray Incorporated

Company Profile

Accuray Incorporated had its IPO on 2007-02-08 under the ticker symbol ARAY.

The company operates in the Healthcare sector and Medical Devices industry. Accuray Incorporated has a staff strength of 1,044 employees.

Stock update

Shares of Accuray Incorporated opened at $2.87 at the start of the last trading session i.e. 2023-03-30.

The stocks traded within a range of $2.81 - $2.92, and closed at $2.91.

This is a +1.39% increase from the previous day's closing price.

A total volume of 220,787 shares were traded at the close of the day’s session.

In the last one week, shares of Accuray Incorporated have increased by +3.19%.

Accuray Incorporated's Key Ratios

Accuray Incorporated has a market cap of $282.66 million, indicating a price to book ratio of 3.8916 and a price to sales ratio of 0.4253.

In the last 12-months Accuray Incorporated’s revenue was $417.44 million with a gross profit of $159.96 million and an EBITDA of $7.28 million. The EBITDA ratio measures Accuray Incorporated's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Accuray Incorporated’s operating margin was 0.55% while its return on assets stood at 0.3% with a return of equity of -23.01%.

In Q4, Accuray Incorporated’s quarterly earnings growth was a negative -96.2% while revenue growth was a negative 6.2%.

Accuray Incorporated’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0.08

Its diluted EPS in the last 12-months stands at $-0.14 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0.08. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Accuray Incorporated’s profitability.

Accuray Incorporated stock is trading at a EV to sales ratio of 0.7332 and a EV to EBITDA ratio of 43.2091. Its price to sales ratio in the trailing 12-months stood at 0.4253.

Accuray Incorporated stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$468.77 million

Total Liabilities

$184.72 million

Operating Cash Flow

$-1534000.00

Capital Expenditure

$1.53 million

Dividend Payout Ratio

0%

Accuray Incorporated ended 2023 with $468.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $468.77 million while shareholder equity stood at $51.75 million.

Accuray Incorporated ended 2023 with $0 in deferred long-term liabilities, $184.72 million in other current liabilities, 95000.00 in common stock, $-500179000.00 in retained earnings and $57.78 million in goodwill. Its cash balance stood at $67.73 million and cash and short-term investments were $67.73 million. The company’s total short-term debt was $10,615,000 while long-term debt stood at $174.10 million.

Accuray Incorporated’s total current assets stands at $336.95 million while long-term investments were $12.28 million and short-term investments were $0. Its net receivables were $89.19 million compared to accounts payable of $33.86 million and inventory worth $155.67 million.

In 2023, Accuray Incorporated's operating cash flow was $-1534000.00 while its capital expenditure stood at $1.53 million.

Comparatively, Accuray Incorporated paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$2.91

52-Week High

$3.67

52-Week Low

$1.7

Analyst Target Price

$8.17

Accuray Incorporated stock is currently trading at $2.91 per share. It touched a 52-week high of $3.67 and a 52-week low of $3.67. Analysts tracking the stock have a 12-month average target price of $8.17.

Its 50-day moving average was $2.84 and 200-day moving average was $2.32 The short ratio stood at 10.65 indicating a short percent outstanding of 0%.

Around 409.1% of the company’s stock are held by insiders while 6158.5% are held by institutions.